IMRX CIK: 1790340

Immuneering Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
152
FY22:
109
FY23:
89.1
FY24:
39.6
FY25:
176
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.4
FY22:
13.6
FY23:
13.5
FY24:
13.1
FY25:
55.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
167
FY22:
122
FY23:
103
FY24:
52.7
FY25:
232

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
5.63
FY22:
8.05
FY23:
7.85
FY24:
7.50
FY25:
10.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.09
FY22:
4.46
FY23:
4.16
FY24:
3.82
FY25:
3.43
(positive)
Change from FY21 to FY25
millions USD
FY21:
156
FY22:
110
FY23:
90.6
FY24:
41.4
FY25:
218
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
167
FY22:
122
FY23:
103
FY24:
52.7
FY25:
232

All amounts in millions USD Data source:SEC EDGAR